PATIENTS CARE ABOUT CURES, NOT CONFLICT OF INTEREST
More than a third of doctors who sit on review boards overseeing the integrity of clinical trials do not bother to disclose a financial stake in the outcome, a study in the New England Journal of Medicine has shown. However this does not shock cancer patients. In the same journal another study found that 80% were “not worried at all” if a doctor profited from a tested drug. In fact, most patients said that they opposed bans on such relationships. The author of the study said that this was quite understandable since participants in clinical trials “are very vulnerable, have a serious problem and want someone to care for it.”
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
War and peace: Israeli physicians treating Palestinian patients
In the midst of the bitter war between Hamas and the Israeli Defense Forces in Gaza, there is a ray...
Court rules ‘voluntary assisted dying’ is suicide
Such is the stigma surrounding suicide that advocates of “voluntary assisted dying” insist vehemently that it is by no means...
Is poverty a cause of the rise of trans identity in the UK?
UK rates of transgender identity have risen at least 5-fold since 2000, with the highest rise observed among 16 to...
Donor anonymity becomes a battleground in the US
Donor-conceived Americans who want the federal government to abolish donor anonymity are getting pushback from the LGBTQI+ lobby. On the...
Should there be a ‘dead donor rule’ for sperm donation?
Sperm donation creates a web of exceedingly complex relationships. The HeyReprotech Newsletter (a great Substack resource for news about assisted...
The oldest mother in Africa is single and broke
A 70-year-old Ugandan woman has given birth to twins after receiving IVF treatment. Safina Namukwaya delivered a boy and a...